For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Alkermes Controlled Therapeutics, Inc. Ii

USPTO Granted Patents = 36

% Expired Patents = 13.9

CIPO Patents = 1

Forward Citations = 1,815

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

J Michael Ramstack (15 out of 44 patents)

Steven G Wright (13 out of 43 patents)

Shawn L Lyons (13 out of 28 patents)

4. Michael E Rickey (13 out of 31 patents)

5. Danny H Lewis (7 out of 30 patents)

6. Thomas J Atkins (6 out of 11 patents)

7. Jean Louis Mesens (6 out of 20 patents)

8. Joyce M Hotz (3 out of 30 patents)

9. Chiem V Pham (3 out of 3 patents)

10. Paul F Herbert (2 out of 12 patents)

11. Henry R Costantino (1 out of 91 patents)

12. Rajesh Kumar (1 out of 14 patents)

13. Kristyn Greco (1 out of 1 patent)

14. Firouz Asgarzadeh (1 out of 1 patent)

15. James I Wright (1 out of 59 patents)

Core Competencies:

Microparticles

Biodegradable Agents

Controlled Release

Poly(D,L-lactide-co-glycolide)

Biocompatible

3-Piperidinyl-Substituted

Solvent Extraction

Hydrogel Copolymers

Neurotransmitter Activity

Growth Promoters

Antiparasitic Agents

36 patents: Sort by Forward Citations

1. 7118763 - Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles (2006-10-10),

2. 7074883 - Acid end group poly(D,L-lactide-co-glycolide) copolymers with high glycolide content (2006-07-11),

3. 6987111 - Aripiprazole, olanzapine and haloperidol pamoate salts (2006-01-17),

4. 6939033 - Method and apparatus for preparing microparticles using in-line solvent extraction (2005-09-06),

5. 6884372 - Method for preparing microparticles using liquid-liquid extraction (2005-04-26),

6. 6861016 - Apparatus and method for preparing microparticles (2005-03-01),

7. 6830737 - Apparatus for preparing microparticles using liquid-liquid extraction (2004-12-14),

8. 6824822 - Residual solvent extraction method and microparticles produced thereby (2004-11-30),

9. 6800663 - Crosslinked hydrogel copolymers (2004-10-05),

10. 6705757 - Method and apparatus for preparing microparticles using in-line solvent extraction (2004-03-16),

11. 6703477 - Acid end group poly(D,L-lactide-co-glycolide) copolymers with high glycolide content (2004-03-09),

12. 6596316 - Preparation of microparticles having a selected release profile (2003-07-22),

13. 6540393 - Apparatus for preparing microparticles using in-line solvent extraction (2003-04-01),

14. 6537586 - Apparatus and method for preparing microparticles (2003-03-25),

15. 6534092 - Method for preparing microparticles having a selected polymer molecular weight (2003-03-18),

Company Overview

Alkermes Controlled Therapeutics, Inc. Ii, based in Cambridge, MA, specializes in the development of innovative pharmaceutical products. The company focuses on addressing unmet medical needs through advanced drug delivery systems and therapeutic solutions. Its research spans various therapeutic areas, including central nervous system disorders and oncology, leveraging proprietary technologies to enhance the efficacy and safety of treatments. Alkermes is committed to improving patient outcomes through scientific excellence and a patient-centered approach.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

36 Patents

#78 in Cambridge, MA

#561 in Massachusetts

#9,516 in US

#18,745 in the World

Cambridge, MA, United States of America

Alkermes Controlled Therapeutics, Inc. Ii

Forward Citations = 1,815

17 inventors:

J Michael Ramstack (15 out of 44 patents)

Steven G Wright (13 out of 43 patents)

Shawn L Lyons (13 out of 28 patents)

4. Michael E Rickey (13 out of 31 patents)

5. Danny H Lewis (7 out of 30 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alkermes Controlled Therapeutics, Inc. Ii. Retrieved from https://idiyas.com/company/alkermes-controlled-therapeutics-ii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…